Real-Time PCR qPCR Market

• Rising Incidence of Genetic Disorders & Life-Threatening Infectious Diseases will boost the market growth

The major factors propelling the growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market during the forecast period include the increasing prevalence of genetic disorders, target infectious disease, increasing use of biomarker profiling for disease diagnostics, and the completion of the Human Genome Project successfully. The need for Digital PCR (dPCR) is anticipated to rise in the next years due to rising technological breakthroughs in PCR technologies, as well as rising investments, funding, and grants.

Growth in the prevalence of target diseases around the world coupled with the proven effectiveness of clinical diagnostic tests like Digital PCR (dPCR) and Real-time PCR (qPCR) Market analysis in the diagnosis and valuation of disease-causing microbes will drive the use of these tests, which are anticipated to help the Market grow throughout the forecast period. During the forecast period, the Real-Time PCR (qPCR) market is expected to grow at a faster rate due to increasing market penetration in emerging nations and a shift in consumer perception from plant-delivered drugs to genome-based drugs.

Additionally, the shift from plant-based to genome-based drug discovery would provide room for the Market for digital PCR (dPCR) and Real-time PCR (qPCR) to expand in the future. Additionally, it is anticipated that during the projection period, the expansion of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market will be constrained by PCR's technological constraints and the rising cost of PCR instruments. Thus, this factor is driving the market CAGR.

For instance, the SARS-CoV-2 ddPCR Kit from Bio-Rad received Emergency Use Authorization (EUA) from the U.S. FDA in September 2020 to be used in the detection of SARS-CoV-2 infection. To lessen the effects of the COVID-19 epidemic, regulatory bodies have also stated their strong support for the approval of these tests. Further, the significance of qPCR and dPCR technologies in genomics research is emphasized by governments and federal bodies throughout the globe. Additionally, during the past ten years, the qPCR and dPCR sectors have experienced financial initiatives from governmental and business entities to support genomic research.

Thus, this aspect will accelerate Real-Time PCR (qPCR) market revenue globally.

The Global Real-Time PCR (qPCR) Market Industry is projected to experience substantial growth over the next decade. With an expected market value of 6.52 USD Billion in 2024, the industry is anticipated to expand at a compound annual growth rate of 6.1% from 2025 to 2035. By 2035, the market could reach 12.5 USD Billion, reflecting the increasing adoption of qPCR technologies across various sectors. This growth trajectory indicates a strong demand for advanced molecular diagnostic tools, driven by factors such as technological advancements, rising healthcare expenditures, and the need for rapid and accurate testing solutions. The market's expansion is likely to create new opportunities for stakeholders in the qPCR ecosystem.

Technological innovations are propelling the Global Real-Time PCR (qPCR) Market Industry forward, enhancing the efficiency and accuracy of qPCR assays. Recent advancements include the development of high-throughput systems and improved reagents that facilitate faster and more reliable results. These innovations not only streamline laboratory workflows but also reduce the cost per test, making qPCR more accessible to a broader range of laboratories. As the industry embraces automation and integration with digital platforms, the market is likely to witness substantial growth. The continuous evolution of qPCR technology suggests a promising future, with the potential to address emerging challenges in molecular diagnostics.

The Global Real-Time PCR (qPCR) Market Industry experiences a robust increase in demand for diagnostic testing across various sectors, including healthcare and agriculture. This surge is attributed to the rising prevalence of infectious diseases and genetic disorders. In 2024, the market is projected to reach 6.52 USD Billion, reflecting the critical role of qPCR in rapid and accurate diagnostics. The technology's ability to provide real-time results enhances its appeal, particularly in clinical settings where timely decision-making is essential. As healthcare providers increasingly adopt qPCR for routine testing, the market is expected to expand significantly, indicating a shift towards more precise diagnostic methodologies.

The increasing awareness of personalized medicine is reshaping the Global Real-Time PCR (qPCR) Market Industry. As healthcare shifts towards tailored treatment approaches, qPCR plays a pivotal role in identifying genetic markers and biomarkers that inform therapeutic decisions. This trend is particularly evident in oncology, where qPCR is utilized to assess tumor characteristics and predict patient responses to specific treatments. The growing emphasis on personalized healthcare solutions is likely to drive market expansion, as healthcare providers seek to implement qPCR technologies to enhance patient outcomes. The integration of qPCR in personalized medicine strategies suggests a transformative impact on the future of healthcare.

Regulatory support for molecular diagnostics is a key factor influencing the Global Real-Time PCR (qPCR) Market Industry. Governments and regulatory bodies are increasingly recognizing the importance of qPCR in disease detection and management. Initiatives aimed at streamlining the approval process for qPCR-based tests are fostering innovation and encouraging market entry. This supportive regulatory environment is likely to enhance the adoption of qPCR technologies across various applications, including clinical diagnostics and research. As regulatory frameworks evolve to accommodate advancements in molecular diagnostics, the market is expected to benefit from increased accessibility and acceptance of qPCR solutions.

Investment in research and development is a driving force behind the expansion of the Global Real-Time PCR (qPCR) Market Industry. Governments and private organizations are allocating significant resources to enhance qPCR technologies and applications. This focus on R&D is crucial for developing novel assays and expanding the utility of qPCR in fields such as oncology, infectious disease, and personalized medicine. The anticipated growth of the market to 12.5 USD Billion by 2035 underscores the importance of innovation in sustaining market momentum. As new applications emerge, the demand for advanced qPCR solutions is expected to rise, further solidifying the market's position within the broader biotechnology landscape.

By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America Real-Time PCR (qPCR) market accounted for USD 2.519 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. Because of the region's high illness prevalence, favorable rules, and several government-sponsored programs to expand the healthcare infrastructure.

Additionally, the substantial presence of well-known manufacturers in the area and the rising need for quick diagnostic tests would be key drivers of the North American Real-Time PCR (qPCR) market throughout the projected period.

Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: REAL-TIME PCR (QPCR) MARKET SHARE BY REGION 2023 (%) 

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

The Asia-Pacific Real-Time PCR (qPCR) Market is anticipated to develop at the fastest CAGR from 2023 to 2030. Due to major advancements in PCR technology made by China and Japan, as well as the growth of healthcare, R&D, and clinical research frameworks by growing nations like India and Australia, the Asia Pacific region is the most profitable Real-Time PCR (qPCR) market. Throughout the anticipated time frame, the Market will have profitable growth prospects. Further, the China Real-Time PCR (qPCR) Market held the largest market share, and the India Real-Time PCR (qPCR) Market was the fastest growing Market in the region.

Europe's Real-Time PCR (qPCR) market accounts for the third-largest market share Real-Time PCR (qPCR) techniques supported by the government and rising demand for Real-Time PCR testing to combat infectious illnesses like COVID-19 are driving the real-time PCR market in Europe. Additionally, the frequency of viral and genetic illnesses, the need for quick diagnoses, and quick technology improvements are all contributing to the real-time PCR (qPCR) Market's expansion. Moreover, U.K. Real-Time PCR (qPCR) Market held the largest market share, and the Germany Real-Time PCR (qPCR) Market was the fastest-growing Market in the region.